The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global ...
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Prime Medicine, Inc. (PRME – Research Report) today and set a price ...
Daryl Brown, who was prescribed the antidepressant Seroxat in childhood because of his Tourette’s syndrome and OCD, tells ...
The FDA has agreed to revisit its decision to prevent compounders from selling versions of Eli Lilly's diabetes and weight ...
Its last remaining monopoly over the China tea trade was abolished in 1833. Parliament allowed the Company to maintain its political and administrative duties in India, but the charter of 1813 ...